Journal of Biomedicine and Biotechnology
Volume 2009 (2009), Article ID 501736, 3 pages
doi:10.1155/2009/501736
Research Article

No Incidence of BRAF Mutations in Salivary Gland Carcinomas—Implications for Anti-EGFR Therapies

Regine Dahse,1 Katrin Kromeyer-Hauschild,2 Alexander Berndt,3 and Hartwig Kosmehl1

1Institute of Pathology, HELIOS Klinikum Erfurt, Nordhauser Str. 74, 99089 Erfurt, Germany
2Institute of Human Genetics and Anthropology, Friedrich Schiller University of Jena, Kollegiengasse 10, 07740 Jena, Germany
3Institute of Pathology, Friedrich Schiller University of Jena, Ziegelmühlenweg, 07740 Jena, Germany

Received 7 April 2009; Accepted 7 May 2009

Academic Editor: Fernando Schmitt

Copyright © 2009 Regine Dahse et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Regine Dahse, Katrin Kromeyer-Hauschild, Alexander Berndt, and Hartwig Kosmehl, “No Incidence of BRAF Mutations in Salivary Gland Carcinomas—Implications for Anti-EGFR Therapies,” Journal of Biomedicine and Biotechnology, vol. 2009, Article ID 501736, 3 pages, 2009. doi:10.1155/2009/501736